These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Hah JM; Martásek P; Roman LJ; Silverman RB J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384 [TBL] [Abstract][Full Text] [Related]
7. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of dipeptide amides containing N omega-nitroarginine and D-2,4-diaminobutyric acids as inhibitors of neuronal nitric oxide synthase. Huang H; Martásek P; Roman LJ; Silverman RB J Enzyme Inhib; 2001; 16(3):233-9. PubMed ID: 11697043 [TBL] [Abstract][Full Text] [Related]
9. Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases. Li H; Flinspach ML; Igarashi J; Jamal J; Yang W; Gómez-Vidal JA; Litzinger EA; Huang H; Erdal EP; Silverman RB; Poulos TL Biochemistry; 2005 Nov; 44(46):15222-9. PubMed ID: 16285725 [TBL] [Abstract][Full Text] [Related]
10. Dipeptides containing L-arginine analogs: new isozyme-selective inhibitors of nitric oxide synthase. Kobayashi N; Higuchi T; Urano Y; Kikuchi K; Hirobe M; Nagano T Biol Pharm Bull; 1999 Sep; 22(9):936-40. PubMed ID: 10513616 [TBL] [Abstract][Full Text] [Related]
11. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Reif DW; McCreedy SA Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822 [TBL] [Abstract][Full Text] [Related]
12. Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. Hah JM; Roman LJ; Martásek P; Silverman RB J Med Chem; 2001 Aug; 44(16):2667-70. PubMed ID: 11472219 [TBL] [Abstract][Full Text] [Related]
13. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050 [TBL] [Abstract][Full Text] [Related]
14. Relative contributions from neuronal and endothelial nitric oxide synthases to regional cerebral blood flow changes during forebrain ischemia in rats. Santizo R; Baughman VL; Pelligrino DA Neuroreport; 2000 May; 11(7):1549-53. PubMed ID: 10841375 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase. Ichimori K; Stuehr DJ; Atkinson RN; King SB J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937 [TBL] [Abstract][Full Text] [Related]
16. The effect of nitric oxide inhibition and temporal expression patterns of the mRNA and protein products of nitric oxide synthase genes during in vitro development of bovine pre-implantation embryos. Tesfaye D; Kadanga A; Rings F; Bauch K; Jennen D; Nganvongpanit K; Hölker M; Tholen E; Ponsuksili S; Wimmers K; Montag M; Gilles M; Kirfel G; Herzog V; Schellander K Reprod Domest Anim; 2006 Dec; 41(6):501-9. PubMed ID: 17107508 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases. Huang H; Martásek P; Roman LJ; Silverman RB J Med Chem; 2000 Jul; 43(15):2938-45. PubMed ID: 10956202 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase isoforms by porphyrins. Wolff DJ; Naddelman RA; Lubeskie A; Saks DA Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750 [TBL] [Abstract][Full Text] [Related]
19. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase. Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957 [TBL] [Abstract][Full Text] [Related]
20. Distinct roles of nitric oxide synthases and interstitial cells of Cajal in rectoanal relaxation. Terauchi A; Kobayashi D; Mashimo H Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G291-9. PubMed ID: 15845873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]